GlassScriptPhysician profile
Mark G Watkins
NPI 1770617029
$3,519.72
in general payments reported to CMS, 2019-2025
20 companies · $119 in 2025
The $119 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,138 · 2020: $262 · 2022: $2,000 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $2,000.00 | 2022 | |
| Mannkind Corporation | $286.09 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $193.99 | 2019-2020 | |
| Medtronic Minimed, INC. | $164.85 | 2019-2020 | |
| Dexcom, INC. | $157.61 | 2019-2020 | |
| Insulet Corporation | $150.99 | 2019 | |
| Gilead Sciences, INC. | $131.06 | 2019-2025 | |
| Novo Nordisk INC | $111.35 | 2019 | |
| Abbott Laboratories | $55.51 | 2019 | |
| Lilly USA, LLC | $49.96 | 2019-2020 | |
| Shire North American Group INC | $43.14 | 2019 | |
| Pfizer INC. | $36.00 | 2019 | |
| Amgen INC. | $23.77 | 2019 | |
| Amarin Pharma, INC. | $22.33 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $18.57 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $18.08 | 2019 | |
| Antares Pharma, INC. | $15.88 | 2019 | |
| Sandoz INC. | $14.09 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.01 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.44 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Watkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.